NewEdge Advisors, LLC

Position in HIMS — Hims & Hers Health, Inc.

CIK 1633516 NEW ORLEANS, LA

Position in HIMS

as of Mar 31, 2026 · filed Jun 3, 2026 Compact

Position Value

$792,471

-$193,740 QoQ

Shares Held

38,173

+25.7% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 41.72582715531921.ToString("F0")% Shared 0.ToString("F0")% None 58.27417284468079.ToString("F0")%

Healthcare · as of Mar 31, 2026

NewEdge Advisors, LLC holds $12,857,221 across 26 Drug Manufacturers - Specialty & Generic names. HIMS ranks #8 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	21,559	$2,548,489
2	VTRS	Viatris Inc	184,938	$2,498,512
3	NBIX	Neurocrine Biosciences Inc	13,066	$1,721,314
4	UTHR	UNITED THERAPEUTICS Corp	2,163	$1,282,615
5	TEVA	Teva Pharmaceutical Industries Ltd	38,245	$1,151,939
6	HLN	Haleon plc	111,815	$1,119,268
7	COLL	Collegium Pharmaceutical, Inc	27,029	$893,849
8	HIMS	Hims & Hers Health, Inc. This page	38,173	$792,471

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$792,471	38,173	+25.7%	Shares	Sole	2026-06-03
2025-12-31	$986,211	30,373	-7.9%	Shares	Sole	2026-02-18
2025-09-30	$1,870,171	32,972	-44.4%	Shares	Sole	2025-11-17
2025-06-30	$2,954,908	59,276	+15099.0%	Shares	Sole	2025-08-14
2025-03-31	$11,524	390	-98.1%	Shares	Sole	2025-05-15
2024-12-31	$484,107	20,021	+83.4%	Shares	Sole	2025-02-13
2024-09-30	$201,072	10,916	+2048.8%	Shares	Sole	2024-11-14
2024-06-30	$10,256	508	-95.0%	Shares	Sole	2024-08-16
2021-03-31	$133,623	10,100	—	Shares	Sole	2021-04-26
No filing history on record for this holder in this stock.